These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 36116761)

  • 21. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
    PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The First Case of a Child Infected with SARS-CoV-2 Omicron Variant in Japan, December 2021.
    Horigome A; Yamanaka J; Takasago S; Iwamoto N; Saito T; Shichino H
    Jpn J Infect Dis; 2023 Jan; 76(1):69-71. PubMed ID: 36047182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incubation Period of COVID-19 Caused by Unique SARS-CoV-2 Strains: A Systematic Review and Meta-analysis.
    Wu Y; Kang L; Guo Z; Liu J; Liu M; Liang W
    JAMA Netw Open; 2022 Aug; 5(8):e2228008. PubMed ID: 35994285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 Variant.
    Cocherie T; Bastide M; Sakhi S; Zafilaza K; Flandre P; Leducq V; Jary A; Burrel S; Louet M; Calvez V; Marcelin AG; Marot S
    Microbiol Spectr; 2022 Oct; 10(5):e0192222. PubMed ID: 36125269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study.
    Cloete J; Kruger A; Masha M; du Plessis NM; Mawela D; Tshukudu M; Manyane T; Komane L; Venter M; Jassat W; Goga A; Feucht U
    Lancet Child Adolesc Health; 2022 May; 6(5):294-302. PubMed ID: 35189083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of the Swiss Digital Contact-Tracing App Over Various SARS-CoV-2 Pandemic Waves: Repeated Cross-sectional Analyses.
    Daniore P; Nittas V; Ballouz T; Menges D; Moser A; Höglinger M; Villiger P; Schmitz-Grosz K; Von Wyl V
    JMIR Public Health Surveill; 2022 Nov; 8(11):e41004. PubMed ID: 36219833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app.
    Visconti A; Murray B; Rossi N; Wolf J; Ourselin S; Spector TD; Freeman EE; Bataille V; Falchi M
    Br J Dermatol; 2022 Dec; 187(6):900-908. PubMed ID: 35869671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant.
    Butt AA; Dargham SR; Loka S; Shaik RM; Chemaitelly H; Tang P; Hasan MR; Coyle PV; Yassine HM; Al-Khatib HA; Smatti MK; Kaleeckal AH; Latif AN; Zaqout A; Almaslamani MA; Al Khal A; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
    Clin Infect Dis; 2022 Aug; 75(1):e361-e367. PubMed ID: 35404391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
    Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC
    Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 self-test uptake and factors associated with self-testing during Omicron BA.1 and BA.2 waves in France, January to May 2022.
    Supplisson O; Charmet T; Galmiche S; Schaeffer L; Chény O; Lévy A; Jeandet N; Omar F; David C; Mailles A; Fontanet A
    Euro Surveill; 2023 May; 28(18):. PubMed ID: 37140451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Impact of Omicron Wave on Pediatric Febrile Seizure.
    Joung J; Yang H; Choi YJ; Lee J; Ko Y
    J Korean Med Sci; 2023 Jan; 38(3):e18. PubMed ID: 36647218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmission Characteristics and Inactivated Vaccine Effectiveness Against Transmission of SARS-CoV-2 Omicron BA.5 Variants in Urumqi, China.
    Wang K; Guo Z; Zeng T; Sun S; Lu Y; Wang J; Li S; Luan Z; Li H; Zhang J; Wang Y; Lu Y; Zhao S
    JAMA Netw Open; 2023 Mar; 6(3):e235755. PubMed ID: 36995713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamics in COVID-19 symptoms during different waves of the pandemic among children infected with SARS-CoV-2 in the ambulatory setting.
    Ben-Tov A; Lotan R; Gazit S; Chodick G; Perez G; Mizrahi-Reuveni M; Patalon T
    Eur J Pediatr; 2022 Sep; 181(9):3309-3318. PubMed ID: 35778524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General practitioner visits after SARS-CoV-2 omicron compared with the delta variant in children in Norway: a prospective nationwide registry study.
    Arntzen SS; Gjefsen HM; Telle KE; Magnusson K; Størdal K; Håberg SE; Kinge JM
    BMJ Paediatr Open; 2022 Aug; 6(1):. PubMed ID: 36053662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nosocomial SARS-CoV-2 transmission in multi-bedded hospital cubicles over successive pandemic waves: Lower mortality but wider spread with Omicron despite enhanced infection-prevention measures.
    Wee LE; Conceicao EP; Aung MK; Aung MO; Yang Y; Arora S; Ko KK; Venkatachalam I
    Infect Dis Health; 2023 May; 28(2):81-87. PubMed ID: 37032572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity.
    Joung SY; Ebinger JE; Sun N; Liu Y; Wu M; Tang AB; Prostko JC; Frias EC; Stewart JL; Sobhani K; Cheng S
    JAMA Netw Open; 2022 Aug; 5(8):e2227241. PubMed ID: 35976645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households - Four U.S. Jurisdictions, November 2021-February 2022.
    Baker JM; Nakayama JY; O'Hegarty M; McGowan A; Teran RA; Bart SM; Mosack K; Roberts N; Campos B; Paegle A; McGee J; Herrera R; English K; Barrios C; Davis A; Roloff C; Sosa LE; Brockmeyer J; Page L; Bauer A; Weiner JJ; Khubbar M; Bhattacharyya S; Kirking HL; Tate JE
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(9):341-346. PubMed ID: 35238860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features and predictive factors related to liver injury in SARS-CoV-2 Delta and Omicron variant-infected patients.
    Deng H; Lin H; Mai Y; Liu H; Chen W
    Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):933-939. PubMed ID: 35482929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529).
    Chun JY; Jeong H; Kim Y
    BMC Med; 2022 Nov; 20(1):451. PubMed ID: 36419108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.